Potentiation of NMDA receptor function through somatostatin release: a possible mechanism for the cognition-enhancing activity of GABAB receptor antagonists
Authors:
- 30 September 2001
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 41 (3) , 301-310
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Enhancement of Memory in Alzheimer Disease With Insulin and Somatostatin, but Not GlucoseArchives of General Psychiatry, 1999
- Selective block of rat and human neocortex GABAB receptors regulating somatostatin release by a GABAB antagonist endowed with cognition enhancing activityNeuropharmacology, 1999
- A presynaptic N‐methyl‐d‐aspartate autoreceptor in rat hippocampus modulating amino acid release from a cytoplasmic poolEuropean Journal of Neuroscience, 1998
- Pharmacologically distinct GABAB receptors that mediate inhibition of GABA and glutamate release in human neocortexBritish Journal of Pharmacology, 1997
- Human brain somatostatin release from isolated cortical nerve endings and its modulation through GABAB receptorsBritish Journal of Pharmacology, 1996
- Phospholipase C activation and Ca2+ mobilization by cloned human somatostatin receptor subtypes 1–5, in transfected COS‐7 cellsFEBS Letters, 1994
- Multiple GABAB receptorsTrends in Pharmacological Sciences, 1993
- Molecular biology of somatostatin receptorsTrends in Neurosciences, 1993
- A synaptic model of memory: long-term potentiation in the hippocampusNature, 1993
- Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementaNature, 1980